Seth Joel Field MD PhD
Diabetes, Lipid Metabolism
Professor of Medicine/Endocrinology, Case Western Reserve University Investigator, Harrington Discovery Institute, University Hospitals Cleveland Medical Center
Join to view full profile
UH Cleveland Medical Center11100 Euclid Ave Department of Medicine-EndocrinologyCleveland, OH 44106
Phone+1 216-844-8500
Fax+1 216-844-3120
Dr. Field is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 1999
Harvard Medical SchoolClass of 1997
Certifications & Licensure
CA State Medical License 2005 - 2028
OH State Medical License 2020 - 2028
MA State Medical License 1999 - 2005
PA State Medical License 1998 - 1999
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 1 citationsOncogenic receptor tyrosine kinase signaling is driven by the Golgi protein GOLPH3 and its interaction with MYO18A.Kyle A Starost, Jagadeeswara R Bommi, Marshall C Peterman, Mengke X McCullough, Matthew D Buschman
Science Signaling. 2026-05-19 - Golgi Drivers of Cancer.Kyle A Starost, Jagadeeswara R Bommi, Prasenjit Mitra, Seth J Field
Sub-Cellular Biochemistry. 2026-01-01 - 20 citationsA multienzyme S-nitrosylation cascade regulates cholesterol homeostasis.Colin T Stomberski, Nicholas M Venetos, Hua-Lin Zhou, Zhaoxia Qian, Bryce R Collison
Cell Reports. 2022-10-25
Press Mentions
Gene Therapy Shows Promise for Alagille Liver Disease: Mouse StudyJune 6th, 2025
Grant Support
- Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer AgentCASE WESTERN RESERVE UNIVERSITY2020–2025
- Targeting A Novel Phosphoinositide Signaling Pathway For Cancer TherapyNational Cancer Institute2009–2010
- Phosphoinositides Provide Unique Insights Into Cell Biology And PathophysiologyOffice Of The Director, National Institutes Of Health2008
- Pi-3-Kinase Signaling Over Physiologic Time-Scales/Response To Insulin Or IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
- Pi-3-Kinase Mediated Signaling By Insulin And IGF-1National Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: